期刊文献+

生育力与早期胚胎发育毒性试验中雄性大鼠阳性模型的建立 被引量:3

Positive modeling study on fertility and early embryo developmental toxicity in SD male rat
下载PDF
导出
摘要 目的:探讨生育力与早期胚胎发育毒性试验中,SD雄鼠交配前的环磷酰胺给药方法,以建立阳性对照模型。方法:SD大鼠按体质量随机分为3组,分别为溶剂对照组、环磷酰胺I组(100mg/kg)、环磷酰胺II组(20mg/kg);环磷酰胺I组和II组分别腹腔注射给予环磷酰胺1次和5次,溶剂对照组给予等量的生理盐水;雄鼠于首次给药后63d开始交配,交配成功后当天检测阴茎勃起功能,随后处死,进行精子活动度和数量检测,腹主动脉采血后检测双氢睾酮、雌二醇和睾酮激素水平,称量睾丸、附睾、包皮腺、前列腺、精囊腺、提肛肌等的质量并计算脏器系数。结果:2个环磷酰胺组雄鼠主要表现为可逆性脱毛。与溶剂对照组比较,体质量和摄食量均明显降低(P<0.05或0.01);雄鼠附属生殖器官质量降低(P<0.01),阴茎勃起潜伏期明显延长(P<0.01),附睾尾精子计数、Ⅰ和Ⅱ级活动精子数及精子活率降低,精子畸形率明显增高(P<0.05或0.01),但激素水平未见明显异常。结论:给予环磷酰胺对于雄性大鼠的生育力产生明显影响,两种给药方式均可建立生育力与早期胚胎发育毒性试验阳性模型。 OBJECTIVE: To establish male rat fertility and early embryo developmental toxicity test (I section) positive control model, cyclophosphamide was given by i.p. before mating. METHODS: Male Sprague-Dawley rats were divided into control group, cyclophosphamide I and eyelophosphamide II groups. Cyclophosphamide groups were given intraperitoneally on day 1 of 9 weeks (100 mg/kg) and the first 5 days of 9 weeks (20 mg/kg). Male rats were sacrificed after mating, the parameters were observed and tested. RESULTS: Positive groups male animals showed reversible depilatory. Animal body weight and then food consumption were decreased significantly when compared with the control group, although no significant differences in the hormone level were found. Weights of auxiliary reproductive organ were significantly decreased, time for penis erection was significantly longer, sperm count and sperm activity ratio were decreased, and sperm malformation rate was increased significantly. CONCLUSION: Cyclophosphamide exeited significant effects on male fertility, and both treatment methods could be used to establish positive fertility and early embryo developmental toxicity test model.
出处 《癌变.畸变.突变》 CAS CSCD 2013年第4期311-315,共5页 Carcinogenesis,Teratogenesis & Mutagenesis
基金 十二五"重大新药创制"科技重大专项(2011ZX09301-005) 上海市实验动物创新行动计划项目(11140901300和11140901303) 上海市人才发展基金(2010031)
关键词 雄性 生殖毒性 生育力 早期胚胎 发育毒性 环磷酰胺 male reproductive toxicity fertility early embryo development toxicity cyclophosphamide
  • 相关文献

参考文献15

  • 1国家食品药品监督管理局.药物研究技术指导原则:2006~2007年[S].北京:中国医药科技出版社,2007: 143-168.
  • 2ICH Steering Committee. Harmonised Tripartite Guideline S5(R2). Detection of toxicity to reproduction for medicinal productsand toxicity to male fertility [EB/OL].[2013-02-01]. http://www.ich.or^products/guidelines/safety/ article/safety—guidelines .html.
  • 3胡文娟,周莉,孙祖越.致畸试验阳性对照的选择[J].毒理学杂志,2010,24(2):162-165. 被引量:14
  • 4孙祖越,周莉,闫晗,何桂林.如何成功开展药物非临床生殖毒性试验[J].中国新药杂志,2011,20(22):2195-2204. 被引量:39
  • 5ICH. M3 (Rl) maintenance of the ICH guideline on non-clinicalsafety studies for the conduct of human clinical trials forpharmaceuticals[EB/OL]. [2013-02-01]. http://www.ich.org/products/guidelines/multidisciplinary/article/multidisciplinary-guidelines.html.
  • 6ICH. M3 (R2) guidance on nonclinical safety studies for theconduct of human clinical trials and marketing authorization forpharmaceuticals. Step 2 versions[EB/OL]. [2013-02-01]. http://www. ich.org/products/guidelines/multidisciplinary/article/multidisciplinary-guidelines.html.
  • 7孙祖越,周莉,闫晗,韩玲.生育调节药物非临床安全性评价研究的特殊性[J].中国药理学通报,2012,28(4):445-450. 被引量:10
  • 8孙祖越,周莉,闫晗,韩玲.药物非临床生殖发育毒性试验中逐案原则的建议[J].中国新药杂志,2012,21(8):836-843. 被引量:26
  • 9Barrow PC. Reproductive toxicity testing for pharmaceuticals underICH[J]. Reprod Toxicol, 2009, 28(2): 172-179.
  • 10Greenberg LH, Tanaka KR. Congenital anomalies probably inducedby cyclophosphamide[J]. JAMA, 1964, 188: 423-426.

二级参考文献88

共引文献78

同被引文献37

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部